These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14895202)

  • 1. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
    GRUBER CM; LEE KS; LASZICZENKO T; GRUBER CM
    Arch Int Pharmacodyn Ther; 1951 Sep; 87(4):402-12. PubMed ID: 14895202
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
    AVELLANEDA M; CASTRO CM; STRITZLER G
    Cardiologia (Basel); 1953; 22(6):321-32. PubMed ID: 13082497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B; HERNANDEZ A; PEREZ STABLE E
    Rev Cubana Cardiol; 1951; 12(4):141-50. PubMed ID: 12994207
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 9. PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.
    NALBANDIAN RM; MADER IJ; BARRETT JL; PEARCE JF; RUPP EC
    JAMA; 1965 May; 192():603-8. PubMed ID: 14284863
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 11. [SKIN NECROSES IN ANTICOAGULANT THERAPY].
    STACHER A
    Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 13. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 14. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate.
    CHATTERJEA JB; SALOMON L
    Br Med J; 1954 Oct; 2(4891):790-2. PubMed ID: 13199310
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of action of tromexan.
    HUNTER RB; TUDHOPE GR
    Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental histopathological studies of the toxicity of indirect anticoagulants].
    COLLI A; BEVILACQUA M
    Haematologica; 1957; 42(1):1-32. PubMed ID: 13428150
    [No Abstract]   [Full Text] [Related]  

  • 19. Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
    GRUBER CM; LEE KS; RIEDERS F
    Arch Int Pharmacodyn Ther; 1952; 90(4):488-97. PubMed ID: 12986946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with tromexan].
    WICKE G
    Arztl Wochensch; 1953 Aug; 8(33):782-8. PubMed ID: 13080079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.